Clinical Trial Update: RSV Vaccine in Transplant Recipients [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating an RSV vaccine in immunosuppressed transplant recipients is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Infection

Drugs mentioned

• RSV vaccine (respiratory syncytial virus vaccine)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Vaccine Response Impaired, Respiratory Syncytial Virus Infections | Phase 3 | Status: RECRUITING